Stanley Lipkowitz

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Cells

Clinical cancer research : an official journal of the American Association for Cancer Research

PloS one

Current oncology reports

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Oct 01 2013

United States

Chief :: Women's Mallignancies Branch/Center for Cancer Research

Publications

Manjari Kundu, Yoshimi Endo Greer, Alexei Lobanov, Lisa A Ridnour, Renee N Donahue, Yeap Ng, Shashi Ratnayake, Donna Voeller, Sarah Weltz, Qingrong Chen, Stephen J Lockett, Maggie Cam, Daoud Meerzaman, David A Wink, Roberto Weigert, Stanley Lipkowitz
TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers. bioRxiv : the preprint server for biology (2024)
Sarah Jenkins, Wei Zhang, Seth M Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S Armstrong, Eric Burton, DeeDee K Smart, Ritu Shah, Cody J Peer, Brett Mozarsky, Oluwatobi Arisa, William Douglas Figg, Tito R Mendoza, Elizabeth Vera, Priscilla Kaliopi Brastianos, Scott L Carter, Mark R Gilbert, Carey K Anders, Caitriona Cahir, Carol Tweed, Karen Lisa Smith, Imran Khan, Stanley Lipkowitz, Patricia S Steeg, Alexandra S Zimmer
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Meredith S Shiels, Stanley Lipkowitz, Nicole G Campos, Mark Schiffman, John T Schiller, Neal D Freedman, Amy Berrington de González
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047. Cancer discovery (2023)
Rohan Wedam, Yoshimi Endo Greer, David J Wisniewski, Sarah Weltz, Manjari Kundu, Donna Voeller, Stanley Lipkowitz
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer. Cancers 15 (7) (2023)
Sarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, Margaret E Gatti-Mays, Nicole Houston, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Christina Burks, Christina M Annunziata, Jung-Min Lee, Kunio Nagashima, Jane B Trepel, Stanley Lipkowitz, Alexandra S Zimmer
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma. The oncologist (2023)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Daniel S Green, Franklin Ning, Anna Duemler, Timothy G Myers, Kathryn Trewitt, Irene Ekwede, Ann McCoy, Nicole Houston, Jung-Min Lee, Stanley Lipkowitz, Alexandra S Zimmer, Miroslava Pavelova, Erin N Villanueva, Leslie Smith, Andrew M Blakely, Yovanni Casablanca, Steven L Highfill, David F Stroncek, Naoza Collins-Johnson, Sandhya R Panch, JoLynn Procter, Chauha Pham, Steven M Holland, Lindsey B Rosen, Ana T Nunes, Kathryn C Zoon, Christopher B Cole, Christina M Annunziata
Intraperitoneal monocytes and interferons as a novel cellular immunotherapy for ovarian cancer: mechanistic characterization and results of a phase I clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sarah Jenkins, Megan E Kachur, Kamil Rechache, Justin M Wells, Stanley Lipkowitz
Rare Breast Cancer Subtypes. Current oncology reports 23 (5) (2021)
Erika J Lampert, Alexandra S Zimmer, Michelle Padget, Ashley Cimino-Mathews, Jayakumar R Nair, Yingmiao Liu, Elizabeth M Swisher, James W Hodge, Andrew B Nixon, Erin Nichols, Mohammad Hadi Bagheri, Elliott Levy, Marc R Radke, Stanley Lipkowitz, Christina M Annunziata, Janis M Taube, Seth M Steinberg, Jung-Min Lee
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Mariya S Liyasova, Ke Ma, Donna Voeller, Philip E Ryan, Jinqiu Chen, Rachel E Klevit, Stanley Lipkowitz
Cbl interacts with multiple E2s in vitro and in cells. PloS one 14 (5) (2019)
Silvano Rakeem Daniels, Mariya Liyasova, Stephen C Kales, Marion M Nau, Philip E Ryan, Jeffrey E Green, Stanley Lipkowitz
Loss of function Cbl-c mutations in solid tumors. PloS one 14 (7) (2019)

Stanley Lipkowitz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stanley Lipkowitz